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activity and affinity for some benzenesulfonamides of human carbonic anhydrase II
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Abstract: Human carbonic anhydrase II (hCA II) enzyme was firstly expressed using a pET-SUMO expression vector in Escherichia coli
and the recombinant enzyme was purified using nickel (Ni2+) affinity chromatography. The substitutions of Trp 209 with four amino
acid (Val, Leu, Ile, and Pro) in the hydrophobic pocket of hCA II were conducted using site-directed mutagenesis. The p-nitrophenyl
esterase activity of hCA II variants correlates with the hydrophobicity and size of residue, suggesting that the hydrophobic character of
this residue is important for catalysis. The Trp 209 was forecast as an important residue and was exposed to computational mutagenesis.
This forecast was confirmed experimentally by producing hCA II mutants and determining the resulting affinities towards some
benzenesulfonamides. These mutations in the hydrophobic pocket of the enzyme active site decreased the protein expression of hCA II
in E. coli, causing the formation of insoluble protein aggregates in many cases. Our findings demonstrated that the Trp 209 in hCA II
plays an important role in the folding process and the valine residues are very compatible for the hydrophobic region in the active cavity
of this isoenzyme. These mutant proteins will lead to a better understanding of structural functions and drug-based studies in the future.
Key words: Computational mutagenesis, enzyme inhibitor, human carbonic anhydrase II, site-directed mutagenesis, sulfonamide

1. Introduction
Carbonic anhydrase (CA, EC 4.2.1.1) is in the
metalloenzyme family and catalyzes the reversible
hydration of CO2 through two steps, as shown in the
following reaction: (i) the formation of HCO3– resulting
from a nucleophilic attack by a Zn–OH– on CO2. (ii)
Transfer of H+ from the Zn–H2O to Zn–OH– for catalysis
of the next reaction (Silverman and Lindskog, 1988; Ekinci
et al., 2011; Senturk et al., 2011).

The human CA (hCA) family involves sixteen different
α-isoforms. Five of them are cytosolic, two different forms
of CA V are mitochondrial, one is secreted in saliva, and
the others are membrane-bound isoforms (Supuran and
Scozzafava, 2007; Supuran, 2008).
* Correspondence: okufrevi@atauni.edu.tr

The active site of mammalian CAs is split into two
parts as hydrophobic and hydrophilic. The hydrophobic
and hydrophilic parts include residues in position 121,
131, 141, 143, 198, and 209 and in position 62, 64, 67,
92, and 200 (Fierke et al., 1991; Elleby et al., 1999; Fisher
et al., 2007; Domsic et al., 2008; Mikulski et al., 2011a,
2011b). Many mutation studies have been done in the
hydrophobic pocket, where the substrate binds (Fierke
et al., 1991; Hunt and Fierke, 1997; Elleby et al., 1999).
Therefore, we decided to carry out the mutation of Trp209
residue in the hydrophobic part of the enzyme active
site cavity. In this study, the mutants of Trp209 caused
modifications of the steric volume in the cavity and then
were investigated how these changes affected the binding
some benzenesulfonamide inhibitors to the active site and
the catalytic activity of hCA II.
We have noted the catalytic properties of four different
mutant enzymes (Trp209Ile, Trp209Leu, Trp209Val, and
Trp209Pro) and the affinity of some benzenesulfonamides
on these mutant enzymes.

835

KILIÇ et al. / Turk J Biol
2. Materials and methods
2.1. Bacterial strains and reagents
Champion pET SUMO Expression System, E. coli One
Shot Mach1-T1R, E. coli BL21 (DE3) One Shot, ProBond
Ni-NTA resin, adult human pancreas cDNA, pETSUMO vector, and SUMO protease were purchased
from Invitrogen (USA). QuikChange II Site-Directed
Mutagenesis Kit and XL10-Gold ultra-competent cells
were obtained from Stratagene. All other analytical grade
chemicals were obtained from Sigma (Germany).
2.2. Cloning of hCA II enzymes and site-directed
mutagenesis
The coding sequence of hCA II (GenBank accession
number NM_000067.2) was amplified by PCR using the
forward primer 5’-ATGTCCCATCACTGGGGGTA-3’ and
the reverse primer 5’-TTATTTGAAGGAAGCTTTGA
TTTGCCTGTT-3’. The PCR process was performed as
follows: 4 min at 94 °C, 35 cycles of 1 min at 94 °C, 1 min
at 60 °C, and 1 min at 72 °C, followed by 10 min at 72
°C. The PCR product was directly ligated into the linear
pET-SUMO vector with 1:1 molar ratio using T4 DNA
ligase overnight at 16 °C according to the manufacturer’s
instructions (Champion pET SUMO protein expression
system kit). Then the ligated product was transformed
into One Shot Mach1-T1R competent E. coli cells. Positive
colonies were chosen from a Luria-Bertani (LB) agar plate
including kanamycin (50 µg/mL). Plasmids were obtained
from the positive colony by using the Plasmid Miniprep
kit. SUMO forward primer and T7 reverse primer were
used to verify DNA sequencing.
Site-directed mutagenesis was performed on the
pET-SUMO-hCA II according to the protocol of the
QuikChange Site-Directed Mutagenesis Kit. The mutant
primers obtained from Methabion as shown in Table 1
were used to perform the site-directed mutagenesis based
on PCR. The PCR reaction mixture was prepared by

adding 10X reaction buffer, template (90 ng), primers (125
ng), dNTP mix, Quik Solution reagent, ddH2O, and finally
QuikChange Lightning Enzyme. The pET-SUMO-hCA II
was amplified as follows: 2 min at 95 °C (first denaturation
step), 18 cycles of 20 s at 95 °C (denaturation), 10 s at 68 °C
(annealing), and 3 min at 68 °C (extension), followed by 5
min at 68 °C (last denaturation step). The amplified product
was digested with DpnI and transformed into XL10-Gold
ultra-competent cells. The MedSanTek Company (Turkey)
performed the sequence analysis to define sequences of
the entire coding region.
2.3. Expression and purification of the wild-type and
mutant hCA IIs
Pilot expression of the wt and mutant hCA IIs was
carried out by inducing with isopropyl-1-thio-β-Dgalactopyrasonide (IPTG). Briefly, an overnight culture
(500 µL) was added to 10 mL of LB broth including
kanamycin (50 µg/mL) and then incubated at 37 °C for
2 h by shaking to mid-log phase (O.D.600∼0.4–0.6). Until
the final concentration was 1 mM, IPTG was added to the
culture and 500 μL of culture was centrifuged at intervals
of an hour (0–6 h) at 10,000 × g for 30 s. The cell pellets
were stored at –20 °C. To determine whether the protein
was expressed, SDS-PAGE analysis of each pellet was
carried out.
Recombinant plasmids of the wt and mutant were
transformed into the E. coli strain BL21 (DE3) for
expression. The cells covering the recombinant proteins
were grown in LB broth with kanamycin (50 µg/mL).
IPTG (1 mM) was added to the culture with optic density
of 0.5 and this culture was incubated at 37 °C for 6 h. To
disrupt harvested cells, pellets were sonicated, frozen, and
thawed, in that order. The proteins were purified using a
ProBond Ni-NTA resin according to the instructions of
the manufacturer. NaH2PO4 buffer (pH 8.0), imidazole
(250 mM), and NaCl (0.5 M) were used to elute the pure

Table 1. Designed primers for site-directed mutagenesis.
Primer

Sequence (5’-3’)

W209I For

5’-GATGGGTTCCTTGAGCACAATTATGGTCACACATTCCAGAAGAGG-3

W209I Rev

5’-CCTCTTCTGGAATGTGTGACCATAATTGTGCTCAAGGAACCCATC-3’

W209L For

5’-GTTCCTTGAGCACAATCAAGGTCACACATTCCAGA-3’

W209L Rev

5’-TCTGGAATGTGTGACCTTGATTGTGCTCAAGGAAC-3’

W209P For

5’-GGTTCCTTGAGCACAATCGGGGTCACACATTCCAGAAG-3’

W209P Rev

5’-CTTCTGGAATGTGTGACCCCGATTGTGCTCAAGGAACC-3’

W209V For

5’-GGGTTCCTTGAGCACAATCACGGTCACACATTCCAGAAGA-3’

W209V Rev

5’-TCTTCTGGAATGTGTGACCGTGATTGTGCTCAAGGAACCC-3’
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proteins. The purity and molecular weight of the purified
SUMO-hCA II was determined by SDS-PAGE analysis
(Supplementary file in Figure S1), using Coomassie blue
staining. The buffer in fractions of the SUMO-hCA II and
mutants was exchanged with Tris-HCl buffer (20 mM pH
8.0, 150 mM NaCl) to digest with SUMO protease and then
concentrated up to 1.5–2 mL using an Amicon filter. To
disrupt the fusion proteins, the mixture was incubated with
SUMO protease at 30 °C for 2–3 h. The digested protein
was verified by SDS-PAGE analysis (Supplementary file in
Figure S2).
2.4. hCA II inhibition experiments
The hCA II activity was measured at 348 nm
spectrophotometrically during the conversion of
4-nitrophenylacetate to 4-nitrophenylate according
to Verpoorte et al. (1967). Inhibition effects of the
compounds
(3,4-diamino-benzenesulfonamide
1,
3-amino-4-chlorobenzenesulfonamide 2, 5-amino-2methylbenzenesulfonamide 3, and acetazolamide 4) on
SUMO fusion the wt and mutant enzymes were analyzed
in their different concentrations. The Cheng–Prusoff
equation was used to determine the Ki values of each
compound (Scott et al., 2009).
2.5. Computational site-directed mutagenesis
The protein crystal structure of hCA II (PDB ID: 2WEJ)
was obtained using the RCSB Protein Data Bank (Maestro,
version 10.5, Schrodinger, LLC; 2015). The Protein
Preparation Wizard (Schrödinger) was used to organize
the protein structures (Sastry et al., 2013). This wizard
assigned bond order and formal charges, incorporated
hydrogens, constructed side chains and loops with missing
atoms, defined the ideal protonation conditions for
ionizable residues, and made a restrained minimization.
Computational mutagenesis was performed using
Maestro, version 10.5, Schrodinger. The Trp209Val,
Trp209Leu, Trp209Ile, and Trp209Pro single-point
mutations were generated using the Residue Scanning
module of BioLuminate and their interactions with nearby
residues were represented using a 2D ligand interaction
diagram (Figure 1). After the mutagenesis, each protein
was optimized and minimized by OPLS_2005 force field
in the wizard. After energy minimization, the important
residues in active site of the mutant structures were
superimposed with the corresponding native structure
(Figure 2).
3. Results
The hydrophobic part (Val 121, Val 143, Leu 198, and Trp
209) in the active site of hCA II is related to both substrate/
inhibitor binding and the catalyst of the CO2 hydration
(Alexander et al., 1991; Domsic et al., 2008; West et al.,
2012).

Both experimental and computational analyses were
performed to understand the functional significance in the
hydrophobic package and to clarify the catalytic function
of Trp 209 in the active site of hCA II. The combination of
the analyses with the mutants obtained in various size and
hydrophobicity helps us to understand the mechanisms
of this residue in the catalytic process well. Therefore, we
exchanged the Trp209 with four hydrophobic residues
(Trp209Ile, Trp209Leu, Trp209Val, and Trp209Pro)
experimentally. In addition, computational mutagenesis of
the Trp209 was performed using Maestro, version 10.5. The
results of the computational mutagenesis are presented in
Table 2; bonds and positions of the mutated residues and
the Trp209 are shown in the 2D ligand interaction diagram
of Maestro (Figure 1). Active site residues and ligand
(benzenesulfonamides) of mutants in the hCA II structure
(PDB: 2WEJ) were superimposed with the corresponding
native structure (Figure 2).
KM and kcat values of hCA II the wt and mutants
(Trp209Leu, Trp209Ile, Trp209Val, and Trp209Pro)
were determined and are presented in Table 3. In
addition to kinetic properties, the affinity for some
benzenesulfonamides was examined for the wt and mutant
enzymes. When compared to the wt, compounds 1–4
showed dramatically reduced affinity for the four mutants
(Table 4). The data of the sequence results were aligned
to confirm the mutations experimentally performed at
position 209 of hCA II (Figure 3).
4. Discussion
Mutants of CA I and CA II have been obtained and enzyme
activities of these mutants have been associated with wildtype in many studies. CO2 and 4-nitrophenylacetate were
used as a substrate in these enzyme assays (Nair et al., 1991;
Nair and Christianson, 1993; Fisher et al., 2005; Jiang et
al., 2008; Kockar et al., 2010; Mikulski et al., 2011a, 2011b;
Wu et al., 2011; Fisher et al., 2012; Turkoglu et al., 2012;
Halder and Taraphder, 2013). The earlier work confirmed
that specific substitutes of residue in the hydrophobic
pocket were related to variations in catalytic rates of hCA
II (Fierke et al., 1991; Krebs et al., 1993; Host and Jonsson,
2008). While the exchanges of Asn67 to Ile, Gln92 to Val,
and Leu204 to Ser in the active site of hCA II were carried
out by Turkoglu et al. (2012), W209I, W209L, W209V,
and W209P mutant enzymes were obtained in our study.
The mutations at Val 143 at the CO2 binding site of hCA II
lead to important modifications in the three-dimensional
protein structure and catalytic activity (Fierke et al.,
1991). In other research, the spectral effects of tryptophan
residues were studied by substituting the tryptophan
residues in hCA II (W5F, W16F, W97C, W123C, W192F,
W209F, and W245C) and also W209G and W209S,
which conserved the hydrophobic face in hCAII, were
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Table 2. Residue scanning results of wild-type and mutants of hCA II enzymes.

Protein

hCA II

Mutations

Total

Hydrophobic

Hydrophilic

Δ Stability
(Solvated) kcal/
mol

W209P

25.7

12.03

12.32

50.07

26.79

W209I

7.99

3.72

3.98

11.35

12.18

W209L

1.67

0.86

0.79

6.84

4.37

W209V

15.56

7.33

7.66

12.81

2.17

Solvent Accessible Area (nm/S2/N)

Δ Stability
(Covalent)
kcal/mol

Figure 1. Molecular interactions along with nearby residues of W209 (А), W209I (B), W209L (C), W209P (D), W209V (E) are
represented in 2D diagrams. Pink arrows symbolize a hydrogen bond interaction with a protein backbone atom (solid line) and a protein
side chain (dashed line). Two-point green line represents π–π stacking.

investigated by mutagenesis (Krebs and Fierke, 1993;
Freskgard et al., 1994).
The mutants of Trp 209 in hCA II assessed in this study
made modifications in the steric volume of the active-site
cavity. The replacement of Trp209 in wild-type (side-chain
volume 229 Å3) by Ile (167 Å3), Leu (167 Å3), Val (140
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Å3), and Pro (113 Å3) exhibited the effect of reduced steric
volume of the active-site cavity. The reduced volume in the
active-site cavity of W209I, W209L, W209V, and W209P
mutant enzymes triggered the fall in catalytic activity.
The W209V mutant showed similar specific activity
compared to the wt enzyme, while the W209P, W209L,

KILIÇ et al. / Turk J Biol

Figure 2. The important residues in active sites of W209I (A), W209L (B), W209P (C), and W209V (D) are superimposed with that of
wild-type. In all superimpose images, W209 is represented in a ball and stick model with salmon pink carbon atoms and white hydrogen
atoms, benzenesulfonamide is represented in a ball and stick model with yellow carbon atoms and blue nitrogen atoms, important
residues (H64, H94, H96, H119, V143, V121, L198, T199 and T200) are represented in a thin tube model with black carbon and red
oxygen atoms, Zn atoms are represented as gray balls, and I209, L209, P209, and V209 in the mutant structure are represented in a ball
and stick model with orange, red, turquoise, and green carbon atoms, respectively.

Table 3. The KM and kcat values of wild-type and mutants of hCA II enzymes (Trp209Leu,
Trp209Ile, Trp209Val, and Trp209Pro).

a

Isoenzymes

Protein details

KM (mM)

kcat (s–1)

hCA II

wt

1.61 ± 0.07

3.30 ± 0.19

hCA II

Trp209Leu

0.75 ± 0.12

1.81 ± 0.11

hCA II

Trp209Ile

0.51 ± 0.06

0.90 ± 0.81

hCA II

Trp209Pro

1.02 ± 0.07

0.35 ± 0.14

hCA II

Trp209Val

0.74 ± 0.07

2.80 ± 0.09

The data performed in triplicate (mean ± SD)
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Table 4. Inhibition of the wild-type and mutants with the compounds 1–4, by an esterase assay.

Compounds

a

Ki (µM)
hCA II

Trp209Pro

Trp209Leu

Trp209Ile

Trp209Val

1

2.03 ± 0.12

969 ± 17

734 ± 6

671 ± 10

541 ± 9

2

9.05 ± 0.11

1209 ± 23

635 ± 6

540 ± 4

242 ± 6

3

2.80 ± 0.02

252 ± 7

125 ± 5

131 ± 7

121 ± 5

4 (AZA)

0.052 ± 0.004

125 ± 4

40.8 ± 3.1

30.3 ± 1.8

8.2 ± 0.8

The data performed in triplicate (mean ± SD)

Figure 3. The sequences of hCA II wild-type and four mutants (Orange arrow represents wt, W209I, W209L, W209P, and W209V.

and W209I mutants were around 60%, 30%, and 20% less
active for p-nitrophenyl esterase activity compared to the
wt enzyme, respectively. The highest decrease in specific
activity among the mutants was observed in Trp209Pro
when compared to the wt. This result indicated the lacking
a hydrophobic pocket could dramatically reduce the
catalytic activity of hCA II.
Although the replacements do not affect to pathway of
the H+ transfer of this enzyme, there were changes in the
rate constant (kcat) that comprise assistance of H+ transfer
between the solvent and the active site. As seen in Table
3, the kcat values for W209L, W209I, and W209P mutants
were reduced by 2-, 3-, and 10-fold, compared with the wt,
respectively, whereas the W209V mutant was very similar
to the wt. The kcat for a proton transfer from His64 to Zn–
OH– during catalysis was 3.30 s–1 for the wt. The W209V
mutant was the fastest isoenzyme, with a value of 2.80 s–1.
The reduction in catalytic rate could be due to the increase
in the active site cavity of the hCA II mutants.
Probably because the distance between substrate and
Zn–OH– is greater in the mutants, the contact formed
with unpaired electrons of the oxygen atom of Zn–OH–
is reduced. The data in Table 3 show that the kcat and KM
values of mutant enzymes were different from those of
the wt. The KM decreased considerably from 1.61 mM
for the wt to 0.51 for the Trp209Ile. Inhibitory effects of
the compounds, a small library of 3 sulfonamides and
1 acetazolamide, against the wt and mutant enzymes
were investigated and it was also determined how they
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affect the inhibitor property (Table 4). The compounds
1–3 are simple aromatic/heterocyclic derivatives largely
investigated by means of structural and inhibition studies,
whereas acetazolamide 4 is a clinically used antiglaucoma
drug. Recently, inhibition studies of CA isoenzymes have
gained considerable attention for medicinal application
(Senturk et al., 2011; Mete et al., 2016). It has been reported
that the benzenesulfonamide derivatives commonly used
in the inhibition of CAs have a potent inhibitory effect on
hCA II (Casini et al., 2000; Cecchi et al., 2004; Innocenti
et al., 2004; Alp et al., 2012; Mete et al., 2016; Yaseen et al.,
2016).
When inhibition constants of the compounds 1–4 were
compared, it was observed that mutants had dramatically
higher values than the wt hCA II. These results showed
that the compounds were less effective in the mutants.
The Ki values of derivatives 1–4 were 125–1209 µM for
the Trp209Pro mutant, 40.8–734 µM for the Trp209Leu
mutant, 30.3–671 µM for the Trp209Ile mutant, and 8.2–
541 µM for the Trp209Val mutant (Table 4). Our results
showed that the highest decrease in the inhibition effect
of this compounds on the enzyme was observed in the
Trp209Pro mutant compared to the wt, followed by the
Trp209Leu and Trp209Ile, while the smallest decrease in
the inhibition effect was detected in the Trp209Val (except
for compounds 3). These values suggested that the Trp209
residue change in the active site may cause significant
irregularities in chemical bond interactions.
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The changes in residue hydrophobicity were evaluated
using the solvent-accessible surface area (SASA) stated
by a water probe radius of 1.4 Å. The changes in total
surface area (Δ SASA total) and in surface area of polar
atoms (Δ SASA polar) and nonpolar atoms (Δ SASA
nonpolar) due to the mutation were determined using
BioLuminate, Schrödinger [16]. Additionally, the changes
in the stability of the protein owing to the mutation
were calculated using the prime energy function with an
implicit solvent term (Table 2). When compared to the wt,
these mutants exhibited the largest change in surface area
in the Trp209Pro, followed by the Trp209Val, Trp209Ile,
and Trp209Leu, whereas the change in covalent stability of
the protein due to the mutation was least in the Trp209Val.
This result showed that the changes in the covalent stability
of the protein were parallel with the changes in enzyme
activity. When superimposed structures were examined,
it was observed that Zn metals and residues (His 94, His
96, and His 119) of wt and Trp209Val overlap in similar
coordinates but not the others. As a result, Figure 2 shows
that protein backbones of the Trp209Val and wt had very
similar structures.
The amino acid residue (Trp 209) involved in the
binding of substrate in the active site of the enzyme having
physiological importance and being abundant was altered
to residues with varying hydrophobicity and size. The

W209V mutant showed similar specific activity values to
the wt, whereas the W209P, W209L, and W209I mutants
were less active around 60%, 30%, and 20% in esterase
assay compared to the wt, respectively. The affinity of some
benzenesulfonamides was also investigated for the mutant
enzymes. When compared to the wt, compounds 1–4
showed dramatically reduced affinity for the four mutants.
These data highlighted the function of the Trp 209 amongst
the amino acids on the hydrophobic part of the active site
in effective catalysis by hCA II. Surprisingly, the Trp209Val
had better catalytic properties among the mutants and
showed higher affinity for benzene sulfonamide inhibitors.
As we know, the hydrophobic pocket of hCA II enzyme
has valine residues (Val 121, Val 143) more than one. Thus,
we concluded that the valine residue is compatible for
the hydrophobic region of activity site of this isoenzyme.
Moreover, our study showed that both the catalytic rate
constants and the specific activity rates are related to the
results of computational mutagenesis.
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Supplemental Content
Figure S1. SDS-PAGE analysis of purified SUMO fusion human carbonic anhydrase II Lane 1: lysate; Lanes 2–3: elution;
Lanes 4–6: unbound-flow through; 7–8: wash; Lane 9: marker.
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Figure S2. SDS-PAGE analysis of cleavage of the SUMO-hCAII fusion protein by SUMO protease. Lane 1: marker; Lane
2: SUMO-hCA II, hCA II, SUMO; Lane 3: SUMO-hCA II.
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